AAAAAA

   
Results: 1-16 |
Results: 16

Authors: MCCALL E ZIMMERMAN K STEINBERG MI
Citation: E. Mccall et al., THE EFFECTS OF A NOVEL SODIUM (NA) CHANNEL ENHANCER ON CONTRACTION INCARDIAC MYOCYTES ISOLATED FROM A RAT MODEL OF HEART-FAILURE, The FASEB journal, 12(4), 1998, pp. 2377-2377

Authors: STEINBERG MI WIEST SA
Citation: Mi. Steinberg et Sa. Wiest, POTENTIATION OF (3)[H]-2-BENZOFURANYL-2-IMIDAZOLINE (BFI) BINDING TO HUMAN PLATELETS BY THE MONOAMINE-OXIDASE INHIBITOR (MAOI), TRANYLCYPROMINE (TCP), The FASEB journal, 12(4), 1998, pp. 2587-2587

Authors: TANIMURA M SHEVLYAGIN S SHIMOYAMA H STEINBERG MI BORZAK S GOLDSTEIN S SABBAH HN
Citation: M. Tanimura et al., LY366634, A NOVEL SODIUM-CHANNEL ACTIVATOR, IMPROVES LEFT-VENTRICULARFUNCTION IN DOGS WITH CHRONIC HEART-FAILURE, Journal of the American College of Cardiology, 29(2), 1997, pp. 8094-8094

Authors: WIEST SA STEINBERG MI
Citation: Sa. Wiest et Mi. Steinberg, BINDING OF [H-3] 2-(2-BENZOFURANYL)-2-IMIDAZOLINE (BFI) TO HUMAN BRAIN - POTENTIATION BY TRANYLCYPROMINE, Life sciences, 60(9), 1997, pp. 605-615

Authors: MCCALL E STEINBERG MI
Citation: E. Mccall et Mi. Steinberg, THE EFFECTS OF LY-368052 ON CONTRACTION IN ISOLATED CARDIAC MYOCYTES, Biophysical journal, 72(2), 1997, pp. 157-157

Authors: WIEST SA STEINBERG MI
Citation: Sa. Wiest et Mi. Steinberg, BINDING OF H-3 2-BENZOFURANYL-2-IMIDAZOLINE (BFI), TO HUMAN BRAIN - POTENTIATION BY TRANYLCYPROMINE, The FASEB journal, 10(3), 1996, pp. 899-899

Authors: SWEENEY RJ GILL RM STEINBERG MI REID PR
Citation: Rj. Sweeney et al., EFFECTS OF FLECAINIDE, ENCAINIDE, AND CLOFILIUM ON VENTRICULAR REFRACTORY PERIOD EXTENSION BY TRANSCARDIAC SHOCKS, PACE, 19(1), 1996, pp. 50-60

Authors: STEINBERG MI
Citation: Mi. Steinberg, SECURITIES LITIGATION DEVELOPMENTS - THE BESPEAKS CAUTION DOCTRINE AND RELATED DEFENSES, Securities regulation law journal, 23(4), 1996, pp. 447-451

Authors: PALKOWITZ AD STEINBERG MI ZIMMERMAN KM THRASHER KJ HAUSER KL BOYD DB
Citation: Ad. Palkowitz et al., SYNTHESIS AND PHARMACOLOGICAL EVALUATION OF A NOVEL SERIES OF 5-ARYL BENZIMIDAZOLE ANGIOTENSIN-II RECEPTOR ANTAGONISTS, Bioorganic & medicinal chemistry letters, 5(9), 1995, pp. 1015-1020

Authors: ZHANG ZH STEINBERG MI
Citation: Zh. Zhang et Mi. Steinberg, LY-97241 ACCELERATES THE APPARENT RATE OF INACTIVATION OF TRANSIENT OUTWARD K- CHARACTERIZATION OF OPEN-CHANNEL BLOCK( CURRENT ), The Journal of pharmacology and experimental therapeutics, 274(1), 1995, pp. 249-257

Authors: STEINBERG MI PALKOWITZ AD THRASHER KJ REEL JK ZIMMERMAN KM WHITESITT CA SIMON RL HAUSER KL LIFER SL PFEIFER W TAKEUCHI K WIEST SA VASUDEVAN V BEMIS KG DEETER JB BARNETT CJ WILSON TM MARSHALL WS BOYD DB
Citation: Mi. Steinberg et al., CHIRAL RECOGNITION OF THE ANGIOTENSIN-II (AT(1)) RECEPTOR BY A HIGHLYPOTENT PHENOXYPROLINE OCTANOAMIDE, Bioorganic & medicinal chemistry letters, 4(1), 1994, pp. 51-56

Authors: PALKOWITZ AD STEINBERG MI THRASHER KJ REEL JK HAUSER KL ZIMMERMAN KM WIEST SA WHITESITT CA SIMON RL PFEIFER W LIFER SL BOYD DB BARNETT CJ WILSON TM DEETER JB TAKEUCHI K RILEY RE MILLER WD MARSHALL WS
Citation: Ad. Palkowitz et al., STRUCTURAL EVOLUTION AND PHARMACOLOGY OF A NOVEL SERIES OF TRIACID ANGIOTENSIN-II RECEPTOR ANTAGONISTS, Journal of medicinal chemistry, 37(26), 1994, pp. 4508-4521

Authors: KORNEL MJ ALI KA STEINBERG MI
Citation: Mj. Kornel et al., SYNTHESIS OF P-AMINOBENZAMIDES OF AMINOPIPERIDAZINES AS POTENTIAL ANTIARRHYTHMIC AGENTS, Journal of heterocyclic chemistry, 31(4), 1994, pp. 967-971

Authors: STEINBERG MI
Citation: Mi. Steinberg, CORPORATE-LAW SYMPOSIUM - THE EMERGENCE OF STATE SECURITIES-LAWS - PARTLY SUNNY SKIES FOR INVESTORS, University of Cincinnati law review, 62(2), 1993, pp. 395-428

Authors: HOBERG TE HOLDERMAN MV KREIDER GP LONG JC SHIPMAN M STEINBERG MI
Citation: Te. Hoberg et al., 1993 CORPORATE-LAW SYMPOSIUM - PRESENTATIONS AND PANEL DISCUSSION, University of Cincinnati law review, 62(2), 1993, pp. 533-572

Authors: LIN HS RAMPERSAUD AA ZIMMERMAN K STEINBERG MI BOYD DB
Citation: Hs. Lin et al., SYNTHESIS AND INVITRO EVALUATION OF RBOXYL)-1-CYCLOALKEN-1-YL]PHENYL]METHYL]IMIDAZOLES AS NONPEPTIDE ANGIOTENSIN-II RECEPTOR ANTAGONISTS, Journal of the Chinese Chemical Society, 40(3), 1993, pp. 273-282
Risultati: 1-16 |